1. Deregulation of Annexin-A1 and Galectin-1 Expression in Precancerous Gastric Lesions: Intestinal Metaplasia and Gastric Ulcer
   Ana Flávia Teixeira Rossi et al, 2014, Mediators of Inflammation CrossRef
2. Targeting CCL11 in the treatment of ovarian cancer
   Brian M Nolen et al, 2010, Expert Opinion on Therapeutic Targets CrossRef
3. Protein tyrosine phosphatase 1B expression contributes to the development of breast cancer
   Shi-chong Liao et al, 2017, J. Zhejiang Univ. Sci. B CrossRef
4. CCL5 as an adjuvant for cancer immunotherapy
   Natalia Lapteva et al, 2010, Expert Opinion on Biological Therapy CrossRef
5. CCR2-V64I genetic polymorphism: a possible involvement in HER2+ breast cancer
   Bruna Karina Banin-Hirata et al, 2016, Clin Exp Med CrossRef
6. The Plasticity of Stem-Like States in Patient-Derived Tumor Xenografts
   Alastair H. Davies et al, 2017 CrossRef
7. An agent-based model of triple-negative breast cancer: the interplay between chemokine receptor CCR5 expression, cancer stem cells, and hypoxia
   Kerri-Ann Norton et al, 2017, BMC Syst Biol CrossRef
8. Biomarker MicroRNAs for Diagnosis of Oral Squamous Cell Carcinoma Identified Based on Gene Expression Data and MicroRNA-mRNA Network Analysis
   Hui Zhang et al, 2017, Computational and Mathematical Methods in Medicine CrossRef
9. CCL5-CCR5 interactions modulate metabolic events during tumor onset to promote tumorigenesis
   Darrin Gao et al, 2017, BMC Cancer CrossRef
10. Enhanced metastatic capacity of breast cancer cells after interaction and hybrid formation with mesenchymal stroma/stem cells (MSC)
    Catharina Melzer et al, 2018, Cell Commun Signal CrossRef
11. Sphingolipids as Mediators of Breast Cancer Progression, Metastasis, Response and Resistance to Chemotherapy
    Benjamin Newcomb et al, 2015 CrossRef
12. Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity
    Sugandha Saxena et al, 2021, Cancer Metastasis Rev CrossRef